嗅觉障碍问卷最小临床重要差异的建立
本研究以慢性鼻窦炎(CRS)患者为对象,采用4种基于分布的方法计算嗅觉障碍问卷阴性陈述(QOD-NS)的最小临床重要差异(MCID)。128例患者术后QOD-NS平均改善4.3±11.0,基线异常者改善9.6±12.9(p<0.001)。各法MCID为2.6至8.6分,平均5.2分。
要点
- QOD-NS的MCID按不同方法为2.6至8.6分,平均5.2分。
- 基线QOD-NS异常者术后更易达到MCID。
核心结论
- 基于分布法计算的QOD-NS的MCID范围为2.6至8.6分,平均为5.2分。
- 按术前QOD-NS评分分层时,术前QOD-NS评分异常的患者多数可达到MCID。
研究设计与样本
- 对慢性鼻窦炎(CRS)患者完成QOD-NS问卷。
- 采用4种分布法计算MCID:二分之一标准差、均值标准误、Cohen效应量d及最小可检测变化,并取4者平均值。
- 共分析128例患者。
主要发现
- 全队列术后QOD-NS评分平均改善4.3±11.0。
- 基线评分异常者术后平均改善9.6±12.9(p<0.001)。
- 各法MCID:标准差法6.5、均值标准误法3.1、Cohen效应量d法2.6、最小可检测变化法8.6。
- 全队列达到MCID的可能性为26%至51%,术前嗅觉异常者为49%至70%。
关键数值与推荐
- QOD-NS的MCID:标准差法6.5分、均值标准误法3.1分、Cohen效应量d法2.6分、最小可检测变化法8.6分,平均5.2分。
- 全队列术后QOD-NS改善4.3±11.0,基线异常者改善9.6±12.9(p<0.001)。
临床怎么用
- 临床可用2.6至8.6分(平均5.2分)作为QOD-NS变化的参考阈值。
- 评估术后嗅觉相关生活质量改善时应结合术前QOD-NS基线水平分层解读。
局限性
- 仅采用基于分布的方法计算MCID,未报告基于锚定法的验证。
- 研究对象为慢性鼻窦炎患者,结论外推至其他人群需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Olfactory-specific quality of life (QOL) can be measured using the Questionnaire of Olfactory Disorders Negative Statements (QOD-NS). Changes in the QOD-NS after treatment can be difficult to interpret since there is no standardized definition of clinically meaningful improvement. METHODS: Patients with chronic rhinosinusitis (CRS) completed the QOD-NS. Four distribution-based methods were used to calculate the minimal clinically important difference (MCID): (1) one-half standard deviation (SD); (2) standard error of the mean (SEM); (3) Cohen's effect size (d) of the smallest unit of change; and (4) minimal detectable change (MDC). We also averaged all 4 of the scores together. Finally, the likelihood of achieving a MCID after sinus surgery using these methods, as well as average QOD-NS scores, was stratified by normal vs abnormal baseline QOD-NS scores. RESULTS: Outcomes were examined on 128 patients. The mean ± SD improvement in QOD-NS score after surgery was 4.3 ± 11.0 for the entire cohort and 9.6 ± 12.9 for those with abnormal baseline scores (p < 0.001). The MCID values using the different techniques were: (1) SD = 6.5; (2) SEM = 3.1; (3) d = 2.6; and (4) MDC = 8.6. The MCID score was 5.2 on average. For the total cohort analysis, the likelihood of reporting a MCID ranged from 26% to 51%, and 49% to 70% for patients reporting preoperative abnormal olfaction. CONCLUSION: Distribution-based MCID values of the QOD-NS range between 2.6 and 8.6 points, with an average of 5.2. When stratified by preoperative QOD-NS scores the majority of patients reporting abnormal preoperative QOD-NS scores achieved a MCID.
引用
- Mattos JL, Schlosser RJ, Mace JC, et al. Establishing the minimal clinically important difference for the Questionnaire of Olfactory Disorders. Int Forum Allergy Rhinol. 2018. PMID: 29719139. doi:10.1002/alr.22135
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。